obesity drugs

Novo Nordisk says Lilly’s advertisements use outdated comparisons that omit the recently approved higher dose of Wegovy.

Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.